Moisturisers in the treatment of foot xerosis in adults: Does cost equate to quality? A randomised, double-blinded clinical trial

A randomised controlled trial to compare efficacy between an expensive moisturiser (Eulactol Heel Balm) and inexpensive moisturiser (Sorbolene cream) in the treatment of foot xerosis in adults

Status

Completed

Phases

Unknown

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12614001076662

Enrollment

Registered

2014-10-07

Start date

2015-02-01

Completion date

2015-04-01

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Trial to test difference in efficacy between an expensive moisturiser (Eulactol Heel Balm) & inexpensive moisturiser (Walker's Sorbolene) in the treatment of foot xerosis over a 4 weeks period. A secondary cost / benefit analysis will also be conducted to help determine 'value for money' of the interventions

Interventions

Moisturiser - Eulactol Heel Balm Active ingredient: urea. 2g topically applied daily for 4 weeks. Applied by clinician to ensure adherence to treatment.

Study design

Allocation

Randomised controlled trial

Intervention model

Parallel

Primary purpose

Treatment

Masking

Blinded (masking used) (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

Male or female aged >18 yrs Diagnosis of xerosis indicated by a SRRC score of >2 in dorsal / plantar foot as diagnosed by clinician Willing and able to provide written consent Bilateral Xerosis

Exclusion criteria

Co-existing dermatological disease which may influence xerosis presentation Co-existing systemic disease which may affect skin physiology Medications which affect skin integrity / physiology Allergies to moisturiser ingredients Concomitant moisturiser, antifungal or steroid use

Outcome results